Papers

11

Total Citations

172

H-Index

6

About

Dr. Shingo Akimoto is a pioneering surgeon-researcher at the forefront of robotic and minimally invasive gastrectomy for gastric cancer. His work centers on the safe implementation and clinical advancement of next-generation surgical platforms, including the hinotori™ Surgical Robot System and the Da Vinci™ SP single-port system. Dr. Akimoto’s major contributions include establishing a practical telesurgical platform using hinotori™ (cited 45 times) and demonstrating the safe performance of robotic gastrectomy by second-generation surgeons under JSES guidelines (35 citations). He has also shown the clinical advantage of standardized robotic total gastrectomy through propensity-score matching (27 citations) and validated the feasibility of minimally invasive gastrectomy after preoperative chemotherapy for advanced gastric cancer (11 citations). With over 170 cumulative citations across his top works, Dr. Akimoto’s research is instrumental in expanding access to robotic surgery, improving patient outcomes, and setting new standards for training and credentialing in Japan. His recent first-in-human experiences with the hinotori™ and Da Vinci™ SP systems mark him as a leader in translating cutting-edge robotic technology into clinical practice.

Research Focus

Key Achievements

6
H-Index
11
Papers
172
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
Establishment of a new practical telesurgical platform using the hinotori™ Surgical Robot System: a preclinical study
45 citations · 2022
📈 Most Prolific Year: 2022 (4 Papers)
🤝 Key Collaborators: 28
🏛 Institutions: Fujita Health University Hospital, Fujita Health University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago